Randomized Phase II Evaluation of Carboplatin and Chip in Advanced Transitional Cell Carcinoma of the Urothelium-Reference-Cited by-同舟云学术

Randomized Phase II Evaluation of Carboplatin and Chip in Advanced Transitional Cell Carcinoma of the Urothelium

Author:

Trump D.L.¹²³⁴⁵,Elson P.¹²³⁴⁵,Madajewicz S.¹²³⁴⁵,Dickman S.H.¹²³⁴⁵,Hahn R.G.¹²³⁴⁵,Harris J.E.¹²³⁴⁵,Vogl S.E.¹²³⁴⁵,

Affiliation:

1. From the University of Wisconsin Clinical Cancer Center, Madison, Wisconsin

2. Dana-Farber Cancer Institute, Harvard School of Public Health, Boston, Massachusetts

3. Albert Einstein College of Medicine, Bronx and Mount Sinai Medical Center, New York, New York

4. Mayo Clinic, Rochester, Minnesota

5. Rush-Presbyterian-St. Luke’s Medical Center, Chicago, Illinois

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference30 articles.

1. Cis-dichlorodiammineplatinum (II) in advanced bladder cancer;Yagoda;Cancer Treat. Rep.,1976

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Role of immunotherapy in bladder cancer;Cancer Treatment and Research Communications;2021